Literature DB >> 3369315

Long-term results in 64 patients operated upon for pheochromocytoma.

G Stenström1, I Ernest, L E Tisell.   

Abstract

During the years 1956-1982, 64 pheochromocytoma patients were operated upon without mortality. Twenty-eight patients had sustained hypertension and 29 paroxysmal hypertension only. In two patients high blood pressure was not related to pheochromocytoma and five subjects were normotensive. In two women the pheochromocytoma demonstrated malignancy by widespread metastases. Sixteen patients also had neuroectodermal manifestations other than pheochromocytoma. Preoperatively, heart disease was found in most of the hypertensive patients aged 50 years or more at operation, but was uncommon in the others. In these subjects, heart disease persisted after surgery. Young subjects with sustained hypertension were not less affected by preoperative cerebrovascular accidents than older subjects. After surgery, hypertension persisted in 12 patients, and was easily controlled by drug therapy in eight. Nine patients died 7 months-18 years after surgery. In no case was the death directly associated with the pheochromocytoma disease. Three died from other neuroectodermal abnormalities. The 55 surviving patients have been followed up for a mean of 12 years after surgery. During the observation time the survival of the pheochromocytoma patients was similar to that of the normal population. At the end of the study, 44 out of the 55 surviving patients were free from symptoms.

Entities:  

Mesh:

Year:  1988        PMID: 3369315     DOI: 10.1111/j.0954-6820.1988.tb15883.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

1.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 2.  SDH-related pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Kathryn S King; Karel Pacak
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 3.  Pheochromocytoma: implications in tumorigenesis and the actual management.

Authors:  U Shah; A Giubellino; K Pacak
Journal:  Minerva Endocrinol       Date:  2012-06       Impact factor: 2.184

4.  The many faces of pheochromocytoma.

Authors:  H K Ghayee; K L Wyne; F S Yau; W H Snyder; S Holt; S Tunc Gokaslan; F Nwariaku
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

5.  [Malignant adrenal pheochromocytoma--problems in evaluating clinical diagnosis and morphologic extent].

Authors:  M Brückner; B C Padberg; M Dürig; S Schröder
Journal:  Langenbecks Arch Chir       Date:  1993

6.  Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990.

Authors:  R Mornex; C Badet; L Peyrin
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 7.  Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Anne-Paule Gimenez-Roqueplo; Massimo Mannelli; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2009-02-03       Impact factor: 5.678

8.  Medical management of pheochromocytoma: Role of the endocrinologist.

Authors:  M K Garg; Sandeep Kharb; K S Brar; Abhay Gundgurthi; Rakesh Mittal
Journal:  Indian J Endocrinol Metab       Date:  2011-10

9.  Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor.

Authors:  Hans K Ghayee; Vikash J Bhagwandin; Victor Stastny; Arielle Click; Liang-Hao Ding; Dario Mizrachi; Ying S Zou; Raj Chari; Wan L Lam; Robert M Bachoo; Alice L Smith; Michael D Story; Stan Sidhu; Bruce G Robinson; Fiemu E Nwariaku; Adi F Gazdar; Richard J Auchus; Jerry W Shay
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms.

Authors:  M Pourian; Davani B Mostafazadeh; A Soltani
Journal:  J Diabetes Metab Disord       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.